DelphX Announces Non-Brokered Unit Private Placement
DelphX plans a small non-brokered unit financing with attached two-year warrants to bolster working capital.
Rhea-AI Summary
DelphX Capital Markets (DPXCF) has launched a non-brokered private placement of up to 5,600,000 units at C$0.01 per unit, for gross proceeds of up to C$56,000.
Each unit comprises one common share and one warrant, with each warrant exercisable into one common share at C$0.06 for two years from issuance. DelphX plans to use net proceeds for working capital and corporate overhead, with no more than 10% of gross proceeds allocated to investor relations activities. The placement is subject to TSX Venture Exchange approval, and the securities will be subject to a four-month-plus-one-day hold period and the Exchange Hold Period.
Positive
- Private placement size up to 5,600,000 units for gross proceeds of up to C$56,000
- Warrants provide potential extra capital at C$0.06 per share for two years
- Use of proceeds directed to working capital and corporate overhead with IR spend capped at 10% of gross proceeds
Negative
- Potential dilution from issuance of up to 5,600,000 new shares plus an equal number of warrants
- Offering price set at C$0.01 per unit, below the C$0.05 level that triggers an Exchange Hold Period
- Financing completion remains conditional on TSX Venture Exchange approval
AI-generated analysis. How Rhea-AI works. Not financial advice.
Toronto, Ontario and New York, New York--(Newsfile Corp. - September 22, 2026) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX" or the "Company"), a leader in the development of new classes of structured products, announces that it has commenced a non-brokered private placement of up to 5,600,000 units of the Company (the "Units") at a subscription price of C
Each Unit consists of one common share of the Company (a "Common Share") and one Common Share purchase warrant (a "Warrant"). Each Warrant entitles the holder to purchase one additional Common Share at an exercise price of C
In connection with the Offering, DelphX may elect to pay finder's fees to eligible finders in accordance with the policies of the TSX Venture Exchange. Details of any finder's fees paid will be announced at a later date.
DelphX intends to use the net proceeds of the Offering for working capital and corporate overhead. No more than
Completion of the Offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of issuance and, as the Units are priced at less than C
About DelphX Capital Markets Inc.
DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:
Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;
Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.
All CPOs and CRNs are fully collateralized and held in custody by US Bank. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.
For more information about DelphX, please visit www.delphx.com.
For further information, please contact:
George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160
Forward-Looking Statements
This news release contains "forward-looking information" within the meaning of applicable Canadian securities laws, including statements regarding the proposed non-brokered private placement, the anticipated gross proceeds and the intended use of proceeds. Forward-looking information is based on the Company's current expectations and assumptions and is subject to risks and uncertainties that could cause actual results to differ materially, including the risk that the Offering is not completed on the terms contemplated or at all, that the Offering is not fully subscribed, or that regulatory approval from the TSX Venture Exchange is not obtained. Readers are cautioned not to place undue reliance on forward-looking information, which speaks only as of the date of this release. The Company undertakes no obligation to update such information except as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/315573
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does each DelphX unit in the private placement include?
Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at an exercise price of C$0.06 for a period of two years from the date of issuance.
How will DelphX use the proceeds from this private placement?
DelphX intends to use the net proceeds from the offering for working capital and corporate overhead. The company states that no more than 10% of the gross proceeds will be used to fund investor relations activities.
What are the resale restrictions on the securities issued in the offering?
The securities issued in the offering will be subject to a hold period of four months plus one day from the date of issuance. Because the units are priced at less than C$0.05 per unit, they will also be subject to the TSX Venture Exchange Hold Period and will be legended accordingly.
Is the DelphX private placement already finalized?
No. Completion of the offering is subject to the approval of the TSX Venture Exchange. The company also indicates that details of any finder’s fees, if paid, will be announced later.